One-Pot Synthesis of Spiro-2H-pyrroles from N-Propargylic β-Enaminones

Eda Karadeniz; Metin Zora

doi:10.1055/s-0037-1611816

Synlett, Inhaltsverzeichnis

Synlett 2019; 30(10): 1231-1236
DOI: 10.1055/s-0037-1611816

letter

One-Pot Synthesis of Spiro-2H-pyrroles from N-Propargylic β-Enaminones

Eda Karadeniz

,

Metin Zora *

Department of Chemistry, Middle East Technical University, 06800 Ankara, Turkey eMail: zora@metu.edu.tr

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

A simple and general one-pot method for the synthesis of spiro-2H-pyrroles has been developed. Initially, cyclohexane-embedded β-enaminones with internal alkyne functionality were synthesized by conjugate addition of 1-ethynylcyclohexylamine to α,β-alkynic ketones, followed by palladium-catalyzed coupling of the resulting N-propargylic β-enaminones with aryl iodides. When subjected to basic conditions, the cyclohexane-embedded β-enaminones with internal alkyne functionality underwent tandem nucleophilic cyclization and benzylic C–H oxidation to furnish 3,4-diaryloyl-1-azaspiro[4.5]deca-1,3-diene derivatives in good yields.

Key words

pyrrole - 2H-pyrrole - N-propargylic β-enaminones - spiro compound - nucleophilic cyclization - benzylic C–H oxidation

Volltext

Referenzen

References and Notes

1a d’Ischia M, Napolitano A, Pezzella A, Trofimov BA, Nedolya NA, Bergman J, Janosik T. In Comprehensive Heterocyclic Chemistry III, Vol. 3. Katritzky AR, Ramsden CA, Scriven EF. V, Taylor RJ. K, Jones G. Pergamon-Elsevier; Oxford: 2008. Chap. 3.01-3.04, 1-388
1b Quin LD, Tyrell JA. Fundamentals of Heterocyclic Chemistry . Wiley; New Jersey: 2010. Chap. 9.2, 222-225
1c Bergman J, Janosik T. In Modern Heterocyclic Chemistry, Vol. 4. Alvaroz-Builla J, Vaquero JJ, Barluenga J. Wiley-VCH; Weinheim: 2011. Chap. 4, 269-375

2a Trofimov BA, Mikhaleva AI, Schmidt EY, Sobenina LN. Chemistry of Pyrroles . CRC Press; Boca Raton: 2015
2b Lopchuk JM. In Progress in Heterocyclic Chemistry, Vol. 28. Gribble GW, Joule JA. Elsevier; Oxford: 2016. Chap. 5.2, 165-218
2c Vessally EA. RSC Adv. 2016; 6: 18619
2d Zhou NN, Zhu HT, Yanga DS, Guan ZH. Org. Biomol. Chem. 2016; 14: 7136
2e Sharma A, Piplani P. J. Heterocycl. Chem. 2017; 54: 27

3a Bhardwaj V, Gumber D, Abbot V, Dhiman S, Sharma P. RSC Adv. 2015; 5: 15233
3b Khajuria R, Dham S, Kapoor KK. RSC Adv. 2016; 6: 37039
3c Mohamed MS, El-Hameed RH. A, Sayed A. J. Adv. Pharm. Res. 2017; 1: 1; DOI: 10.21608/APRH.2017.16155
3d Kaur R, Rani V, Abbot V, Kapoor Y, Konar D, Kumar K. J. Pharm. Chem. Chem. Sci. 2017; 1: 17

4a Rios R. Chem. Soc. Rev. 2012; 41: 1060
4b Molvi KI, Haque N, Awen BZ. S, Zameeruddin M. World J. Pharm. Pharm. Sci. 2014; 3: 536
4c Ziarani GM, Moradi R, Lashgari N. ARKIVOC 2016; (i): 1
4d Kotha S, Panguluri NR, Ali R. Eur. J. Org. Chem. 2017; 5316
4e Vacala TL, Carlson PR, Arreola-Hester A, Williams CG, Makhoul EW, Vadola PA. J. Org. Chem. 2018; 83: 1493

5a Aldeghi M, Malhotra S, Selwood DL, Chan AW. E. Chem. Biol. Drug Des. 2014; 83: 450
5b Richie TJ, Macdonald SJ. Drug Discovery Today 2009; 14: 1011

6a Zheng Y, Tice CM, Singh SB. Bioorg. Med. Chem. Lett. 2014; 24: 3673
6b Santos MM. M. Tetrahedron 2014; 70: 9735
6c Gubba Reddy BV, Gopal Reddy S, Durgaprasad M, Bhadra MP, Sridhar B. Org. Biomol. Chem. 2015; 13: 8729

7a Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. N. Engl. J. Med. 2001; 345: 851
7b Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. N. Engl. J. Med. 2008; 359: 2456

8a Kuhl H. Climacteric 2005; 8: 3
8b Wiesinger H, Berse M, Klein S, Gschwend S, Hochel J, Zollmann FS, Schutt B. Br. J. Clin. Pharmacol. 2015; 80: 1399

9a Claire M, Faraj H, Grassy G, Aumelas A, Rondot A, Auzou G. J. Med. Chem. 1993; 36: 2404
9b Friedman AJ. Cutis. 2015; 96: 216

10a Cheruku SR, Padmanilayam MP, Vennerstrom JL. Tetrahedron Lett. 2003; 44: 3701
10b Basaric N, Marinic Z, Sindler-Kulyk M. J. Org. Chem. 2006; 71: 9382
10c Savarin CG, Grise C, Murry JA, Reamer RA, Hughes DL. Org. Lett. 2007; 9: 981
10d Zhuo CX, Liu WB, Wu QF, You SL. Chem. Sci. 2012; 3: 205
10e Wu KJ, Dai LX, You SL. Chem. Commun. 2013; 49: 8620
10f Zhuo CX, Cheng Q, Liu WB, Zhao Q, You SL. Angew. Chem. Int. Ed. 2015; 54: 8475

For reviews, see:

11a Vessally E, Hosseinian A, Edjlali L, Bekhradnia A, Esrafili MD. RSC Adv. 2016; 6: 71662
11b Arshadi S, Vessally E, Edjlali L, Ghorbani-Kalhor E, Hosseinzadeh-Khanmiri R. RSC Adv. 2017; 7: 13198

For selected studies, see:

12a Cacchi S, Fabrizi G, Filisti E. Org. Lett. 2008; 10: 2629
12b Karabiyikoglu S, Kelgokmen Y, Zora M. Tetrahedron 2015; 71: 4324
12c Cheng G, Weng Y, Yang X, Cui X. Org. Lett. 2015; 17: 3790
12d Goutham K, Kumar DA, Suresh S, Sridhar B, Narender R, Karunakar GV. J. Org. Chem. 2015; 80: 11162
12e Kelgokmen Y, Cayan Y, Zora M. Eur. J. Org. Chem. 2017; 7167
12f Zora M, Dikmen E, Kelgokmen Y. Tetrahedron Lett. 2018; 59: 823
12g Kelgokmen Y, Zora M. J. Org. Chem. 2018; 83: 8376

13 Karadeniz E, Zora M. Synthesis 2019; 51: 2157

14a Modern Oxidation Methods, 2nd ed. Backvall JE. Wiley-VCH; Weinheim: 2010
14b Comprehensive Organic Chemistry II, Vol. 7. Knochel P, Molander GA. Pergamon-Elsevier; Oxford: 2014

15a Moriyama K, Takemura M, Togo H. Org. Lett. 2012; 14: 2414
15b Liu J, Zhang X, Yi H, Liu C, Liu R, Zhang H, Zhuo K, Lei A. Green Chem. 2014; 16: 2344
15c Sterckx H, De Houwer J, Mensch C, Herrebout W, Tehrani KA, Maes BU. W. Beilstein J. Org. Chem. 2016; 12: 144
15d Yang Y, Ma H. Tetrahedron Lett. 2016; 57: 5278
15e Kolsi LE, Krogerus S, Brito V, Ruffer T, Lang H, Yli-Kauhaluoma J, Silvestre SM, Moreira VM. ChemistrySelect 2017; 2: 7008

16 Schiltz GE, Uyanik M, Ishihara K. In Comprehensive Organic Chemistry II, Vol. 6. Knochel P, Molander GA. Pergamon-Elsevier; Oxford: 2014. Chap. 6.13 and 6.14, 555-597

17a Rao HS. P, Jothilingam S. J. Org. Chem. 2003; 68: 5392
17b Rao HS. P, Jothilingama S, Scheeren HW. Tetrahedron 2004; 60: 1625
17c Luo H, Kang Y, Li Q, Yang L. Heteroat. Chem. 2008; 19: 144
17d Gardikis Y, Tsoungas PG, Potamitis C, Pairas G, Zervou M, Cordopatisa P. Heterocycles 2011; 83: 1291
17e Auria MD, Guarnaccio A, Racioppi R, Santagata A, Teghil R. Synlett 2013; 24: 943
17f Xin L, Xue J, Lei G, Qiao J. RSC Adv. 2015; 5: 42354
17g Shi X, Gopalakrishna TY, Wang Q, Chi C. Chem. Eur. J. 2017; 23: 8525
17h Baumgartner K, Kirschbaum T, Krutzek F, Dreuw A, Rominger F, Mastalerz M. Chem. Eur. J. 2017; 23: 17817

18 (2-Phenyl-1-azaspiro[4.5]deca-1,3-diene-3,4-diyl)bis(phenylmethanone) (5a); Typical Procedure: To a stirred solution of 1,3-diphenyl-3-((1-(phenylethynyl)cyclohexyl)amino)prop-2-en-1-one (3a; 106.5 mg, 0.263 mmol) in DMSO (3 mL) under air, was added Cs₂CO₃ (256.7 mg, 0.788 mmol) and the resulting solution was allowed to stir at 80 °C until all starting material was consumed as monitored by TLC (ca. 30 min). When the reaction was complete, the mixture was cooled to room temperature and diluted with chloroform (30 mL). To the diluted reaction mixture, an equal volume of ice was added, the mixture stirred for 10 minutes and the organic layer was separated from the aqueous layer. The aqueous layer was extracted with chloroform (2 × 15 mL) and the combined organic layers were dried over MgSO₄, filtered and evaporated on a rotary evaporator to give the crude product, which was purified by flash chromatography on silica gel eluting with hexane/ethyl acetate (9:1 followed by 4:1) to afford spiro-2H-pyrrole 5a (76.1 mg, 69%) as a yellow solid (R_f = 0.44 in 4:1 hexane/ethyl acetate; mp 172.4–174.6 °C). ¹H NMR (400 MHz, CDCl₃): δ = 7.56–7.52 (m, 2 H), 7.49 (m, 2 H), 7.45–7.42 (m, 2 H), 7.41–7.34 (m, 2 H), 7.30–7.15 (m, 7 H), 2.13–1.97 (m, 4 H), 1.83 (d, J = 13.2 Hz, 1 H), 1.78–1.67 (m, 2 H), 1.56 (d, J = 11.0 Hz, 2 H), 1.35–1.24 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 194.5 (CO), 192.9 (CO), 170.9 (C), 166.7 (C), 137.8 (C), 137.2 (C), 137.1 (C), 134.0 (CH), 133.9 (CH), 133.7 (C), 130.1 (CH), 129.5 (CH), 129.3 (CH), 128.7 (CH), 128.6 (CH), 128.5 (CH), 128.5 (CH), 85.3 (C), 33.8 (CH₂), 25.6 (CH₂), 23.8 (CH₂). IR (neat): 3057, 2913, 2857, 1657, 1597, 1578, 1445, 1337, 1315, 1296, 1258, 1154, 1071, 866, 744, 720, 688 cm^–1. MS (ESI): m/z 420.20 [M + H]⁺. HRMS (ESI): m/z [M + H]⁺ calcd for C₂₉H₂₆NO₂: 420.1958; found: 420.1968.
19 Hernandes MZ, Cavalcanti SM. T, Moreira DR. M, de Azevedo Jr. WF, Leite AC. L. Curr. Drug Targets 2010; 11: 303

20a Park BK, Kitteringham NR, O’Neill PM. Annu. Rev. Pharmacol. Toxicol. 2001; 41: 443
20b Filler R, Saha R. Future Med. Chem. 2009; 1: 777
20c Liang T, Neumann CN, Ritter T. Angew. Chem. Int. Ed. 2013; 52: 8214
20d Wang J, Sanchez-Rosello M, Acena JL, del Pozo C, Sorochinsky AE, Fustero S, Soloshonok VA, Liu H. Chem. Rev. 2014; 114: 2432

21a Park KK, Tsou LK, Hamilton AD. Synthesis 2006; 3617
21b Chebolu R, Bahuguna A, Sharma R, Mishra VK, Ravikumar PC. Chem. Commun. 2015; 51: 15438

Zusatzmaterial

Supporting Information